Q32 Bio (QTTB) Total Current Liabilities (2017 - 2026)

Q32 Bio has reported Total Current Liabilities for 10 years, with the latest figure at $10.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 26.82% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $10.7 million (down 26.82% YoY), and the FY2025 full-year result was $11.3 million, down 31.09% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $10.7 million, down from $11.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $33.0 million in Q1 2024, with the low at $10.7 million in Q1 2026.
• Average Total Current Liabilities over 5 years is $18.3 million, with a median of $17.2 million recorded in 2024.
• Year-over-year, Total Current Liabilities surged 78.06% in 2024 and sank 55.76% in 2025.
• Tracing QTTB's Total Current Liabilities over 5 years: stood at $22.6 million in 2022, then plunged by 37.5% to $14.1 million in 2023, then advanced by 16.7% to $16.5 million in 2024, then tumbled by 31.09% to $11.3 million in 2025, then declined by 5.97% to $10.7 million in 2026.
• The last three Total Current Liabilities figures came in at $10.7 million (Q1 2026), $11.3 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.

Peer Comparison